The document summarizes a thesis project studying the effects of nisin and doxorubicin in a DMBA-induced skin cancer model. The study evaluated the synergism between nisin, an antimicrobial peptide, and doxorubicin against skin carcinogenesis. Results showed that the combination therapy was more effective at decreasing tumor burden, volume, and multiplicity than either drug alone. Histological analysis and TUNEL assay indicated the combination therapy increased apoptosis in skin tissues. Biomarkers also suggested the combination therapy induced greater oxidative stress than either drug alone. Overall, the results suggest that nisin may help combat developing drug resistance when used as an adjunct to doxorubicin.